Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Economic analysis of alternative pembrolizumab and nivolumab dosing strategies at an academic cancer center. Hall, E., Zhang, J., Kim, E., Hwang, G., Bhatia, S., Reddy, S. A. AMER SOC CLINICAL ONCOLOGY. 2019
View details for DOI 10.1200/JCO.2019.37.15_suppl.6504
View details for Web of Science ID 000487345806058